Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
Baxter

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for MedPointe Healthcare Inc. v. Apotex Inc. (D. Del. 2007)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in MedPointe Healthcare Inc. v. Apotex Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for MedPointe Healthcare Inc. v. Apotex Inc. (D. Del. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-04-17 1 Complaint States Patent No\ 5,164,194 ("tlte ‘194 patent"). Tiiis action is based upon the Patent LaWs …|llllll usoo5164 lam {11§ Patent Numl)er: {45] Date of Patent: 5,164,194 Nov. 17, 1992 [54] AZEI.ASTINB…§ 156 PATENT NO. : 5,164,194 ISSU`ED : November 17, 1992 INVHNTOR(S) : Helmut Hettche PATENT OWNER :…SLR Document 1-2 Filed 04/17/2007 Page 5 of 7 5,164,194 5 lt is also possible to add to the formulations…-cv-00204-SLR Document 1-2 Filed 04/17/2007 5,164,194 7 ized lactose are then incorporated in portions External link to document
2007-06-19 11 Answer to Counterclaim MedPointe admits that United States Patents No` 3,813,384, 4,704,387, 3,878,217, 4,254,129, 4,313,931, 4,43()…art patent In the paragraph bridging columns 6 and 7 of that patent, the '384 prior art patent discloses…owner of U'nited States Patent Nc)q 5,164,194 ("the '194 patent"), entitled “Azeiastine…COUNTERCLAIM PARAGRAPH 14 `fhe ’194 patent issued Noveinber 17, 1992 from patent application number 07/551,644…admits that the '194 patent issued on November 17, 1992 from U‘Sn patent application serial number External link to document
2007-04-18 4 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,164,194; (ead) (Entered: 04…HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 5,164,194 …Inc.; Apotex Corp. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
2008-04-21 40 Consent Judgment infringement of United States Patent No. 5,164,194 ("the '194 Patent") in connection With Apotex…the '194 Patent, within the United States before the expiration of the 'l 94 Patent is an act of…Court has subject matter jurisdiction over this patent infringement action (the "Action") and… 2 of 4 3. In response to Meda's charge of patent infringement, Apotex has alleged certain defenses… and counterclaims, including that the '194 Patent is invalid, unenforceable and not infringed by External link to document
2008-04-21 41 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,164,194; (Attachments: # 1 …infringement of United States Patent No. 5,164,194 ("the '194 Patent") in connection With Apotex… l 5,164,194 11/17/92 Asta Phanna AG 2 3 4 5 ln the aboveientitled case, the following patent(s)/… Apotex Corp. PATENT OR DATE OF PATENT TRADEMARK NO' OR TRADEMARK HOLDER OF PATENT OR TRADEMARK …EI Other Pleading PATENT OR DATE OF PATENT TRADEMARK NO‘ OR TRADEMARK HOLDER OF PATENT OR TRADEMARK l External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
McKinsey
Dow
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.